Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
119
datasets available to search
ShareScore release 0.9.0
Dataset results
119 results for “Bismuth”
High Dose of Dual Therapy Plus Bismuth for Helicobacter Pylori Treatment
ClinicalTrials.gov study NCT03405584. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy, Vonoprazan-amoxicillin Dual Therapy and Proton Pump Inhibitor-based Standard Triple Therapy for Hp Eradication
ClinicalTrials.gov study NCT06349486. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tegoprazan-Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for H. Pylori Infection (TATH-1)
ClinicalTrials.gov study NCT05647278. IPD Sharing: NO. Countries: 1. Publications: 0.
Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment
ClinicalTrials.gov study NCT07139366. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy and Bismuth Quadruple Therapy
ClinicalTrials.gov study NCT07358130. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy of a 14-Day Bismuth-Containing Quadruple Therapy Guided by Drug Susceptibility Testing in Patients with Extremely Refractory Helicobacter Pylori Infection: an Exploratory Study
ClinicalTrials.gov study NCT06731023. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Efficacy of the Combination Bismuth + Neomycin + Procaine in the Treatment of Recurrent Aphthous Ulceration
ClinicalTrials.gov study NCT00857688. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study To Assess The Efficacy And Safety Of Bismuth Tripotassium Dicitrate (De-Nol) In Combination With Pantoprazole And Pantoprazole Monotherapy In Treatment Of Subjects With Nonsteroidal Anti-Infla
ClinicalTrials.gov study NCT02788123. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ILTHPI - Comparison of Medicament Containing Tetracycline, Metronidazole, Bismuth Versus Amoxicillin, Metronidazole, Clarithromycin
ClinicalTrials.gov study NCT04853875. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study on the Efficacy and Safety of Berberine, Minocycline, Esomeprazole, and Colloidal Bismuth Quadruple Therapy in the Initial Treatment of Helicobacter Pylori.
ClinicalTrials.gov study NCT06603688. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacies of HDDT With or Without Bismuth vs Amoxicillin-metronidazole BQT for First-line H Pylori Eradication
ClinicalTrials.gov study NCT03897244. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment Efficacy of Regimens With and Without Bismuth in Children With Helicobacter Pylori-Associated Peptic Ulcer Disease
ClinicalTrials.gov study NCT07260006. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Ilaprazole Based Bismuth-containing Quadruple Regimen for the First-line Treatment of Helicobacter Pylori Infection
ClinicalTrials.gov study NCT02835560. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Study the Effect of Probiotics Combined With Bismuth Quadruple Rescue Therapy on H Pylori Infective Patients
ClinicalTrials.gov study NCT03297242. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Eradication of Helicobacter Pylori With Bismuth Agent Quadruple and Traditional Chinese Medicine
ClinicalTrials.gov study NCT05586464. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Effectiveness of Minocycline-Containing Bismuth Quadruple Therapy for Helicobacter Pylori Eradication
ClinicalTrials.gov study NCT04558502. IPD Sharing: NO. Countries: 0. Publications: 0.
Adding Bismuth to Rabeprazole-based First-line Triple Therapy Does Not Improve the Eradication of Helicobacter Pylori
ClinicalTrials.gov study NCT03108287. IPD Sharing: NO. Countries: 0. Publications: 0.
Transcriptomic analysis of Pseudomonas aeruginosa under the treatment of bismuth subsalicylate(BSS), eravacycline or the combination
GEO Series GSE223542. Pseudomonas aeruginosa. 8 samples. Type: Expression profiling by high throughput sequencing.
Data set from Marrocco-Trischitta MM, Rylski B, Schofer F, Secchi F, Piffaretti G, de Beaufort H, Belvroy V, Bismuth J, Czerny M, Trimarchi S. Prevalence of type III arch configuration in patients with type B aortic dissection. Eur J Cardiothorac Surg. 2019 Dec 1;56(6):1075-1080. doi: 10.1093/ejcts/ezz137. Erratum in: Eur J Cardiothorac Surg. 2019 Dec 1;56(6):1208. PMID: 31038681.
<p>Data set from Marrocco-Trischitta MM, Rylski B, Schofer F, Secchi F, Piffaretti G, de Beaufort H, Belvroy V, Bismuth J, Czerny M, Trimarchi S. Prevalence of type III arch configuration in patients with type B aortic dissection. Eur J Cardiothorac Surg. 2019 Dec 1;56(6):1075-1080. doi: 10.1093/ejcts/ezz137. Erratum in: Eur J Cardiothorac Surg. 2019 Dec 1;56(6):1208. PMID: 31038681.</p> <p> </p> <p>The abstract:</p> <p><strong>Objectives: </strong>Type III aortic arch configuration consistently presents anatomical and biomechanical characteristics which have been associated with an increased risk of type B aortic dissection (TBD). Our aim was to investigate the prevalence of type III arch in patients with TBD and type B intramural haematoma (IMH-B).</p> <p><strong>Methods: </strong>A multicentre retrospective analysis was performed on patients with TBD and IMH-B observed between 2002 and 2017. The computed tomographic images were reviewed to identify the type of aortic arch. Exclusion criteria included previous arch surgery, presence of aortic dissection or aneurysm proximal to the left subclavian artery and bovine arches. An ad hoc systematic literature review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines to assess the prevalence of type III arch in non-TBD and non-aneurysmal patients.</p> <p><strong>Results: </strong>Two hundred and sixty-one patients with TBD/IMH-B were found to be suitable for the study and were stratified according to aortic arch classification. The ad hoc literature search provided 10 relevant articles, from which a total of 7983 control cases were retrieved. TBD/IMH-B patients were significantly younger than controls [64.3, standard error: 0.74 (62.84-65.76) vs mean pooled age 70.5, standard error: 0.40 (69.71-71.28)]. Patients with TBD/IMH-B presented with a significantly higher prevalence of type III arch [41.0% (107/261) (35.2-47.1)] than controls [16% (1241/7983) (10-22)].</p> <p><strong>Conclusions: </strong>Our data indicate an association between type III arch configuration and the occurrence of TBD/IMH-B. These findings warrant further studies to disclose the potential role of type III arch configuration as an anatomical risk factor for TBD/IMH-B.</p> <p> </p> <p> </p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.